Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus

Published:2013-05-16 Issue:7 Volume:53 Page:711-720
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Struemper Herbert¹,Chen Cecil²,Cai Wendy²

Affiliation:

1. GlaxoSmithKline; Research Triangle Park; NC; USA

2. Human Genome Sciences, Inc.; Rockville; MD; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.104/fullpdf

Reference26 articles.

1. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus;Cancro;J Clin Invest.,2009

2. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis;Bosello;J Rheumatol.,2008

3. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases;Cheema;Arthritis Rheum.,2001

4. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura;Emmerich;Br J Haematol.,2007

5. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome;Groom;J Clin Invest.,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Human Subcutaneous Bioavailability of Therapeutic Monoclonal Antibodies from Systemic Clearance and Volume of Distribution;Molecular Pharmaceutics;2024-09-03

2. Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus;Pharmacology Research & Perspectives;2024-08

3. Rapid and simple quantification of belimumab in human plasma using ultra-high performance liquid chromatography with tandem mass spectrometry;Clinical Biochemistry;2024-02

4. Progress in Clinical Research on Belimumab in the Treatment of Rheumatic Diseases;Advances in Clinical Medicine;2024

5. Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application;Journal of Pharmaceutical and Biomedical Analysis;2023-11